ERBB2 and invasive breast carcinoma: To our knowledge, this is the largest study to test the concordance rates for receptor factors and Ki67 between CNB and OEB, and to evaluate the prognostic value of Ki67 change after CNB in invasive breast cancer patients with different HER2 status.